1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

Pfizer Inc. (NYSE: PFE) Share Price and News

$27.07 $-0.35 (-1.3%) 21 March 2026 at 2:31:47 am AEDT

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 21-03-2026, 02:31:47am AEDT
Current Price $27.07
Change $-0.35 (-1.3%)
Close Price $27.41
Open Price $27.41
Bid $27.06
Ask $27.07
Day Range $26.92 - $27.55
Year Range $20.92 - $27.94
Volume 13,202,619
Average Volume 44,848,748
Market Cap $263,198,126,084.00
Earnings Per Share $1.36

Pfizer Inc. (NYSE: PFE)
Latest News

Share Market News

ASX 200 to surge higher after Pfizer COVID-19 vaccine success

| James Mickleboro

It looks set to be a fantastic day for the S&P/ASX 200 Index (ASX:XJO) on Tuesday after strong results from Pfizer's COVID-19…

Read more »

International Stock News

Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada

| Eric Volkman

Health Canada will determine BNT162b2's suitability for approval as clinical trial data comes in.

Read more »

person receiving coronavirus vaccine injection into the arm
International Stock News

3 reasons Pfizer and BioNTech will have coronavirus vaccine data before Moderna

| Brian Orelli, PhD

Different clinical trial designs gives the duo an advantage, but coming in first isn't the end goal for vaccine makers.

Read more »

doctor giving little boy vaccine injection in his arm
International Stock News

Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

| Brian Orelli, PhD

The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

Read more »

gloved hand injecting coronavirus vaccine into person's arm
International Stock News

Coronavirus vaccine trial adverse event was probably unrelated to treatment

| Brian Orelli, PhD

The paused clinical trial has already resumed.

Read more »

International Stock News

Pfizer says it could know if its COVID-19 vaccine candidate works in October

| Todd Campbell

The drugmaker's CEO said there was a more than 60% chance that they would know by the end of next…

Read more »

doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
International Stock News

The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

| Keith Speights

Hint: It's not Moderna.

Read more »

International Stock News

What if more than one company wins the coronavirus vaccine race?

| Alex Carchidi

The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the…

Read more »

CSL share price represented by hand in blue glove picks out a vial labelled 'covid-19 vaccine' from a row of vials
International Stock News

Coronavirus vaccine race: 7 key things you'll want to know

| Keith Speights

Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

Read more »

Patient wearing mask gets COVID vaccine injection
International Stock News

AstraZeneca coronavirus vaccine clinical trial paused

| Brian Orelli, PhD

One participant fell ill, but the connection to treatment with AZD122 is unclear.

Read more »

International Stock News

How to invest in coronavirus vaccine stocks

| Keith Speights

Just follow these three simple steps.

Read more »

Blue gloved hands holding up vials with covid vaccine labels
International Stock News

In the race for a coronavirus vaccine, can there be multiple winners?

| Adria Cimino

Demand says we may need several players crossing the finish line.

Read more »

Profile

since

Note